|
US7053041B1
(en)
*
|
1996-05-31 |
2006-05-30 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of αvβ5mediated angiogenesis
|
|
MX9801228A
(es)
*
|
1995-08-14 |
1998-05-31 |
Scripps Research Inst |
METODOS Y COMPOSICIONES UTILES PARA LA INHIBICION DE ANGIOGENESIS MEDIADA POR ALFAV beta5.
|
|
US20040063790A1
(en)
*
|
1996-05-31 |
2004-04-01 |
The Scripps Research Institute |
Methods for inhibition of angiogenesis
|
|
US20050281821A1
(en)
*
|
1999-01-06 |
2005-12-22 |
Flavia Pernasetti |
Method and composition for angiogenesis inhibition
|
|
DE60045314D1
(de)
*
|
1999-10-06 |
2011-01-13 |
Kaneka Corp |
Verfahren zur herstellung eines polyimidharzes
|
|
WO2002066073A1
(en)
*
|
2001-02-21 |
2002-08-29 |
Eisai C0. Ltd. |
Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression
|
|
US7019108B2
(en)
*
|
2001-06-01 |
2006-03-28 |
University Of Southern California |
Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2
|
|
ES2243744T3
(es)
*
|
2001-08-01 |
2005-12-01 |
Merck Patent Gmbh |
Inhibidores de integrina para el tratamiento de enfermedades de los ojos.
|
|
US7301006B2
(en)
*
|
2002-07-16 |
2007-11-27 |
Wisconsin Alumni Research Foundation |
Methods and materials for the synthesis of modified peptides
|
|
FR2856598B1
(fr)
*
|
2003-06-25 |
2005-10-28 |
Inst Nat Sante Rech Med |
Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale
|
|
EP2275445A3
(en)
|
2004-03-12 |
2012-02-29 |
Vasgene Therapeutics, Inc. |
Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
|
|
RU2361614C2
(ru)
*
|
2004-03-24 |
2009-07-20 |
ПиДиЭл БАЙОФАРМА, ИНК. |
ПРИМЕНЕНИЕ АНТИТЕЛ ПРОТИВ α5β1 ДЛЯ ИНГИБИРОВАНИЯ ПРОЛИФЕРАЦИИ РАКОВЫХ КЛЕТОК
|
|
NZ550110A
(en)
*
|
2004-04-14 |
2009-09-25 |
Genentech Inc |
Compositions and methods comprising an EGFL7 antagonist for modulating vascular development
|
|
US7973134B2
(en)
*
|
2004-07-07 |
2011-07-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
|
|
CA2581423A1
(en)
|
2004-09-23 |
2006-03-30 |
Vasgene Therapeutics, Inc. |
Polipeptide compounds for inhibiting angiogenesis and tumor growth
|
|
US7935790B2
(en)
*
|
2004-10-04 |
2011-05-03 |
Cell Singaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
|
|
US7807789B2
(en)
*
|
2004-12-21 |
2010-10-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
|
|
SG171481A1
(en)
*
|
2005-01-03 |
2011-06-29 |
Hoffmann La Roche |
Hemopexin-like structure as polypeptide-scaffold
|
|
EP1902725B1
(en)
*
|
2005-02-24 |
2014-03-26 |
The Scripps Research Institute |
Revascularization of ischemic retinal tissue
|
|
US20090099340A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
US20060286148A1
(en)
*
|
2005-05-18 |
2006-12-21 |
Ppd, Inc. |
Method of forming implants
|
|
AU2006283174A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Cell-Matrix, Inc. |
Combination therapies for inhibiting integrin-extracellular matrix interactions
|
|
US20100151495A9
(en)
*
|
2005-08-31 |
2010-06-17 |
Cell Signaling Technolgy, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
WO2007027906A2
(en)
*
|
2005-08-31 |
2007-03-08 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
|
US20080289578A1
(en)
*
|
2005-09-20 |
2008-11-27 |
Rybarczyk Jr Phillip L |
Methods for Rapidly and Accurately Locating Avian Egg Blastoderms
|
|
PT2500030E
(pt)
*
|
2005-11-04 |
2015-09-24 |
Genentech Inc |
Uso de inibidores da via do complemento para tratar doenças oculares
|
|
US8075884B2
(en)
|
2006-01-12 |
2011-12-13 |
Alexion Pharmaceuticals, Inc. |
Antibodies to OX-2/CD200 and uses thereof
|
|
US7976842B2
(en)
*
|
2006-02-09 |
2011-07-12 |
Micromet Ag |
Treatment of metastatic breast cancer
|
|
US20090298093A1
(en)
*
|
2006-04-27 |
2009-12-03 |
Roberto Polakiewicz |
Reagents for the Detection of Protein Phosphorylation in ATM & ATR Kinase Signaling Pathways
|
|
EP1862541A1
(en)
*
|
2006-06-01 |
2007-12-05 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Polypeptides derived from the hemopexin-like domain of metalloproteinase MMP-2
|
|
US7939636B2
(en)
*
|
2006-08-11 |
2011-05-10 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in c-Src signaling pathways
|
|
US20090258442A1
(en)
*
|
2006-08-31 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
CA2677007A1
(en)
|
2007-02-01 |
2008-08-07 |
Acceleron Pharma Inc. |
Activin-actriia antagonists and uses for treating or preventing breast cancer
|
|
EP1972639A3
(en)
|
2007-03-07 |
2008-12-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
US20090068684A1
(en)
*
|
2007-03-26 |
2009-03-12 |
Cell Signaling Technology, Inc. |
Serine and threoninephosphorylation sites
|
|
US20080238709A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Faramarz Vaziri |
One-way communication apparatus with dynamic key generation
|
|
US7977462B2
(en)
|
2007-04-19 |
2011-07-12 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
EP1983003A3
(en)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
EP2145902A3
(en)
|
2007-04-19 |
2010-09-29 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
US20090053831A1
(en)
|
2007-05-01 |
2009-02-26 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
JP2010539236A
(ja)
|
2007-09-18 |
2010-12-16 |
アクセルロン ファーマ， インコーポレイテッド |
アクチビン−ＡｃｔＲＩＩａ拮抗薬およびＦＳＨ分泌を低減または阻害するための使用
|
|
US20090203043A1
(en)
|
2007-11-21 |
2009-08-13 |
Peter Hornbeck |
Protein phosphorylation by basophilic serine/threonine kinases in insulin signaling pathways
|
|
US20090220991A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
|
MX346362B
(es)
|
2009-11-10 |
2017-03-15 |
Allegro Pharmaceuticals Inc * |
Composiciones y metodos para inhibir la adhesion celular o dirigir agentes de diagnostico o terapeuticos a sitios de enlace rgd.
|
|
US11673914B2
(en)
|
2009-11-10 |
2023-06-13 |
Allegro Pharmaceuticals, LLC |
Peptide therapies for reduction of macular thickening
|
|
RU2429836C1
(ru)
*
|
2010-04-01 |
2011-09-27 |
Максуд Мухамеджанович Расулов |
СРЕДСТВО, СТИМУЛИРУЮЩЕЕ ЭКСПРЕССИЮ МАТРИЧНОЙ РНК ТРИПТОФАНИЛ-тРНК-СИНТЕТАЗЫ
|
|
NZ610230A
(en)
*
|
2010-10-07 |
2015-07-31 |
Aerpio Therapeutics Inc |
Compositions and methods for treating ocular edema, neovascularization and related diseases
|
|
WO2012154894A2
(en)
|
2011-05-09 |
2012-11-15 |
Allegro Pharmaceuticals, Inc. |
Integrin receptor antagonists and their methods of use
|
|
WO2013149219A2
(en)
|
2012-03-30 |
2013-10-03 |
Sorrento Therapeutics Inc. |
Fully human antibodies that bind to vegfr2
|
|
CN110191721A
(zh)
|
2016-09-26 |
2019-08-30 |
集合集团控股公司 |
有淋巴系统失调的受试者中癌症的评估与治疗方法
|
|
KR102630070B1
(ko)
*
|
2017-03-31 |
2024-01-26 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
알파-v 베타-3-양성인 암 줄기 세포(csc)를 표적화하여 사멸시키고 약물 내성 암을 치료하기 위한 조성물 및 방법
|
|
CN113663929A
(zh)
*
|
2021-09-24 |
2021-11-19 |
深圳市广利达精密机械有限公司 |
一种自动化机械加工零件自动加工分拣设备及其方法
|